AVA-04-VbP

N/A

Report date: 2023/04/02 16:42:10
NME

Base Information

Drug NameAVA-04-VbP
Drug Alias NameAVA04-VbP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsImmunologic cytotoxicityProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew England Medical Center, Tufts University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNew England Medical Center, Tufts University School Of Medicine
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A